Veru to report fiscal 2025 second quarter financial results on may 8

Miami, may 01, 2025 (globe newswire) -- veru inc. (nasdaq: veru), a late clinical stage biopharmaceutical company focused on developing innovative medicines for the treatment of cardiometabolic and inflammatory diseases, today announced it will host a conference call and audio webcast on thursday, may 8, 2025, at 8:00 a.m. et to discuss its fiscal 2025 second quarter financial results and to provide a business update.
VERU Ratings Summary
VERU Quant Ranking